{
    "N/R/U": null,
    "Applicant": "Novo Nordisk Inc.",
    "BLA Number": "103665",
    "Proprietary Name": "Novoseven, Novoseven Rt",
    "Proper Name": "Coagulation Factor VIIa (Recombinant)",
    "BLA Type": "351(a)",
    "Strength": "4.8MG",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Vial",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "November 15, 2000",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "5000",
    "Submission Type": "Supplement",
    "License Number": "1261",
    "Product Number": "003",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "July 02, 2021"
}